257 related articles for article (PubMed ID: 14605496)
1. Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid.
Breborowicz A; Breborowicz M; Oreopoulos DG
Am J Nephrol; 2003; 23(6):471-6. PubMed ID: 14605496
[TBL] [Abstract][Full Text] [Related]
2. l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro.
Breborowicz A; Wisniewska J; Moberly JB; Oreopoulos DG
Am J Kidney Dis; 1999 Oct; 34(4):663-8. PubMed ID: 10516347
[TBL] [Abstract][Full Text] [Related]
3. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products.
Breborowicz A; Witowski J; Polubinska A; Pyda M; Oreopoulos D
Nephrol Dial Transplant; 2004 Dec; 19(12):3005-11. PubMed ID: 15507476
[TBL] [Abstract][Full Text] [Related]
4. L-2-oxothiazolidine-4-carboxylic acids slow down dialysate-induced senescence in human peritoneal mesothelial cells.
Sosinska-Zawierucha P; Mackowiak B; Begier-Krasinska B; Hoppe K; Breborowicz A
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802216
[TBL] [Abstract][Full Text] [Related]
5. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
6. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine.
Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A
Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595
[TBL] [Abstract][Full Text] [Related]
7. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.
Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ
Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188
[TBL] [Abstract][Full Text] [Related]
8. Effects of glutathione supplementation during peritoneal dialysis.
Styszynski A; Wieczorowska-Tobis K; Podkowka R; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2006; 22():88-93. PubMed ID: 16983947
[TBL] [Abstract][Full Text] [Related]
9. Alterations of intraperitoneal inflammation by the addition of L-2-oxothiazolidine-carboxylate.
Korybalska K; Breborowicz A; Wieczorowska-Tobis K; Polubinska A; Moberly J; Martis L; Oreopoulos DG
Adv Perit Dial; 1997; 13():197-200. PubMed ID: 9360680
[TBL] [Abstract][Full Text] [Related]
10. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells.
Lee SK; Kim BS; Yang WS; Kim SB; Park SK; Park JS
Kidney Int; 2001 Jul; 60(1):55-64. PubMed ID: 11422736
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of viability of human peritoneal mesothelial cells with glutathione precursor: L-2-oxothiazolidine-4-carboxylate.
Breborowicz A; Witowski J; Martis L; Oreopoulos DG
Adv Perit Dial; 1993; 9():21-4. PubMed ID: 8105926
[TBL] [Abstract][Full Text] [Related]
12. L-2-Oxothiazolidine-4-carboxylate and N-acetylcysteine as precursors of intracellular glutathione in human peritoneal mesothelial cells.
Breborowicz A; Patrikarea A; Martis L; Oreopoulos DG
Blood Purif; 1996; 14(1):1-7. PubMed ID: 8718558
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyaluronan-supplemented dialysate on in vitro function of human peritoneal mesothelial cells.
Breborowicz A; Pyda M; Moberly J; Martis L; Oreopoulos D
Am J Nephrol; 2004; 24(3):316-21. PubMed ID: 15148458
[TBL] [Abstract][Full Text] [Related]
14. Effect of glucose polymer on the intercellular junctions of cultured human peritoneal mesothelial cells.
Ito T; Yorioka N; Kyuden Y; Asakimori Y; Kiribayashi K; Ogawa T; Kohno N
Nephron Clin Pract; 2003; 93(3):c97-105. PubMed ID: 12660418
[TBL] [Abstract][Full Text] [Related]
15. The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Wisniewska J; Tam P; French I; Wu G
Adv Perit Dial; 1998; 14():31-5. PubMed ID: 10649686
[TBL] [Abstract][Full Text] [Related]
16. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C.
Haslinger B; Mandl-Weber S; Sellmayer A; Lederer SR; Sitter T
Nephron; 2001 Apr; 87(4):346-51. PubMed ID: 11287779
[TBL] [Abstract][Full Text] [Related]
17. Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid.
Tang S; Leung JC; Chan LY; Tsang AW; Chen CX; Zhou W; Lai KN; Sacks SH
Clin Exp Immunol; 2004 Apr; 136(1):85-94. PubMed ID: 15030518
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of pyruvate upon cultured mesothelial cells exposed to 2 mM hydrogen peroxide.
Shostak A; Gotloib L; Kushnier R; Wajsbrot V
Nephron; 2000 Apr; 84(4):362-6. PubMed ID: 10754414
[TBL] [Abstract][Full Text] [Related]
19. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
20. In vitro simulation of the effect of peritoneal dialysis solution on mesothelial cells.
Breborowicz A; Rodela H; KaroĊ J; Martis L; Oreopoulos DG
Am J Kidney Dis; 1997 Mar; 29(3):404-9. PubMed ID: 9041217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
